These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27480395)

  • 1. Microtomographic studies of subdivision of modified-release tablets.
    Wilczyński S; Koprowski R; Duda P; Banyś A; Błońska-Fajfrowska B
    Int J Pharm; 2016 Sep; 511(2):899-912. PubMed ID: 27480395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Discrepancy between the European Pharmacopoeia Test and an Adopted United States Pharmacopoeia Test Regarding the Weight Uniformity of Scored Tablet Halves: Is Harmonization Required?
    Zaid AN; Ghoush AA; Al-Ramahi R; Are'r M
    PDA J Pharm Sci Technol; 2012; 66(1):20-7. PubMed ID: 22307659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Matrix Technology on the Subdivision of Sustained Release Matrix Tablets.
    Teixeira MT; Sa-Barreto LL; Taveira SF; Gratieri T; Gelfuso GM; Marreto RN; Silva IC; Cunha-Filho M
    AAPS PharmSciTech; 2019 Dec; 21(1):8. PubMed ID: 31797144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tablets of multi-unit pellet system for controlled drug delivery.
    Chen T; Li J; Chen T; Sun CC; Zheng Y
    J Control Release; 2017 Sep; 262():222-231. PubMed ID: 28774838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compaction of, and drug release from, coated drug pellets mixed with other pellets.
    Lundqvist AE; Podczeck F; Newton JM
    Eur J Pharm Biopharm; 1998 Nov; 46(3):369-79. PubMed ID: 9885311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tablet splitting: Product quality assessment of metoprolol succinate extended release tablets.
    Zhao N; Zidan A; Tawakkul M; Sayeed VA; Khan M
    Int J Pharm; 2010 Nov; 401(1-2):25-31. PubMed ID: 20849940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance of scored tablet halves produced by Palestinian Pharmaceutical Companies with the new European Pharmacopoeia requirements.
    Zaid AN; Ghosh AA
    Arch Pharm Res; 2011 Jul; 34(7):1183-9. PubMed ID: 21811926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a real time release approach for manufacturing tablets using NIR spectroscopy.
    Pestieau A; Krier F; Thoorens G; Dupont A; Chavez PF; Ziemons E; Hubert P; Evrard B
    J Pharm Biomed Anal; 2014 Sep; 98():60-7. PubMed ID: 24880992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry.
    Ciavarella AB; Khan MA; Gupta A; Faustino PJ
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):523-532. PubMed ID: 27974592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method for the preparation of sustained release-coated Metoprolol Succinate pellet-containing tablets.
    Yang Z; Yu J; Yang T; Xing H; Zhang J; Xian L; Ding P; Wang D
    Pharm Dev Technol; 2016 Dec; 21(8):943-950. PubMed ID: 26334840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-destructive method for quality control of the pellet distribution within a MUPS tablet by terahertz pulsed imaging.
    Novikova A; Markl D; Zeitler JA; Rades T; Leopold CS
    Eur J Pharm Sci; 2018 Jan; 111():549-555. PubMed ID: 29056403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring dissolution profiles of single controlled-release drug pellets.
    Bhakta HC; Lin JM; Grover WH
    Sci Rep; 2020 Nov; 10(1):19734. PubMed ID: 33184351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a market surveillance study in The Netherlands on break-mark tablets.
    Barends DM; Groot DW; van der Steen JC; de Kaste D; Frijlink HW
    Pharmeur Sci Notes; 2006 Dec; 2006(2):1-7. PubMed ID: 17691208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raman spectroscopy for the analytical quality control of low-dose break-scored tablets.
    Gómez DA; Coello J; Maspoch S
    J Pharm Biomed Anal; 2016 May; 124():207-215. PubMed ID: 26962721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mini-tablets versus pellets as promising multiparticulate modified release delivery systems for highly soluble drugs.
    Gaber DM; Nafee N; Abdallah OY
    Int J Pharm; 2015 Jul; 488(1-2):86-94. PubMed ID: 25869450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS).
    Abdul S; Chandewar AV; Jaiswal SB
    J Control Release; 2010 Oct; 147(1):2-16. PubMed ID: 20493217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a multiple-unit tablet containing enteric-coated pellets.
    Dreu R; Ilić I; Srčič S
    Pharm Dev Technol; 2011 Apr; 16(2):118-26. PubMed ID: 20088675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are There Differences in the Homogeneity of the Parts of Tablets Obtained after Subdivision?-A Preliminary Assessment Using an X-ray Microtomography.
    Meisner M; Kuśnierz P; Duda P; Wilczyński S; Sarecka-Hujar B
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.